147 related articles for article (PubMed ID: 8799555)
1. Effects of beta-adrenoceptor antagonists on Ca(2+)-overload induced by lysophosphatidylcholine in rat isolated cardiomyocytes.
Chen M; Hashizume H; Abiko Y
Br J Pharmacol; 1996 Jun; 118(4):865-70. PubMed ID: 8799555
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidylcholine induces Ca2+-independent cellular injury attenuated by d-propranolol in rat cardiomyocytes.
Chen M; Hashizume H; Xiao CY; Hara A; Abiko Y
Life Sci; 1997; 60(3):PL57-62. PubMed ID: 9000651
[TBL] [Abstract][Full Text] [Related]
4. Effects of antiischemic drugs on veratridine-induced hypercontracture in rat cardiac myocytes.
Hashizume H; Akiyama K; Abiko Y
Eur J Pharmacol; 1994 Dec; 271(1):1-8. PubMed ID: 7698192
[TBL] [Abstract][Full Text] [Related]
5. [Cardiac cell injury induced by lysophosphatidylcholine].
Hashizume H; Abiko Y
Nihon Yakurigaku Zasshi; 1999 Nov; 114(5):287-93. PubMed ID: 10621942
[TBL] [Abstract][Full Text] [Related]
6. A new approach to the development of anti-ischemic drugs: protective drugs against cell injury induced by lysophosphatidylcholine.
Hashizume H; Chen M; Ma H; Hara A; Yazawa K; Akahira M; Xiao CY; Abiko Y
Life Sci; 1998; 62(17-18):1695-9. PubMed ID: 9585159
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of Ca2+ channel blockers on Ca2+ overload induced by lysophosphatidylcholine in cardiomyocytes.
Chen M; Xiao CY; Hashizume H; Abiko Y
Eur J Pharmacol; 1997 Aug; 333(2-3):261-8. PubMed ID: 9314043
[TBL] [Abstract][Full Text] [Related]
8. Extracellulary administered lysophosphatidylcholine causes Ca2+ efflux from freshly isolated adult rat cardiomyocytes.
Itoh K; Yoshizumi M; Kitagawa T; Fukuta Y; Hori T; Houchi H; Tamaki T; Katoh I
Basic Res Cardiol; 1998 Feb; 93(1):23-9. PubMed ID: 9538934
[TBL] [Abstract][Full Text] [Related]
9. A new approach to the development of anti-ischemic drugs. Substances that counteract the deleterious effect of lysophosphatidylcholine on the heart.
Hashizume H; Hoque AN; Magishi K; Hara A; Abiko Y
Jpn Heart J; 1997 Jan; 38(1):11-25. PubMed ID: 9186278
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase A2 is not responsible for lysophosphatidylcholine-induced damage in cardiomyocytes.
Chen M; Xiao CY; Hashizume H; Abiko Y
Am J Physiol; 1998 Nov; 275(5):H1782-7. PubMed ID: 9815086
[TBL] [Abstract][Full Text] [Related]
11. Ethanol delays and reverses lysophosphatidylcholine-induced calcium overload in neonatal rat heart cells.
Gailis L; Lamarche J; Boudriau S; Chahine M; Daleau P
Pflugers Arch; 2001 Oct; 443(1):48-53. PubMed ID: 11692265
[TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidylcholine-induced Ca(2+)-overload in isolated cardiomyocytes and effect of cytoprotective drugs.
Ver Donck L; Verellen G; Geerts H; Borgers M
J Mol Cell Cardiol; 1992 Sep; 24(9):977-88. PubMed ID: 1433324
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine increases cytosolic calcium in ventricular myocytes by direct action on the sarcolemma.
Woodley SL; Ikenouchi H; Barry WH
J Mol Cell Cardiol; 1991 Jun; 23(6):671-80. PubMed ID: 1658342
[TBL] [Abstract][Full Text] [Related]
14. A study on dilazep: II. Dilazep attenuates lysophosphatidylcholine-induced mechanical and metabolic derangements in the isolated, working rat heart.
Hoque AN; Hoque N; Hashizume H; Abiko Y
Jpn J Pharmacol; 1995 Mar; 67(3):233-41. PubMed ID: 7630041
[TBL] [Abstract][Full Text] [Related]
15. Magnesium antagonizes the actions of lysophosphatidyl choline (LPC) in myocardial cells: a possible mechanism for its antiarrhythmic effects.
Prielipp RC; Butterworth JF; Roberts PR; Black KW; Zaloga GP
Anesth Analg; 1995 Jun; 80(6):1083-7. PubMed ID: 7762833
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the heart sarcolemmal Ca2+ transport activity by some beta-adrenergic antagonists.
Dzurba A; Ganguly PK; Guerin A; Dhalla NS
Basic Res Cardiol; 1984; 79(6):620-6. PubMed ID: 6152393
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of quinaprilat and trandolaprilat, active metabolites of quinapril and trandolapril, on hemolysis induced by lysophosphatidylcholine in human erythrocytes.
Hayase N; Satomi M; Hara A; Awaya T; Shimizu K; Matsubara K
Biol Pharm Bull; 2003 May; 26(5):712-6. PubMed ID: 12736518
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and bronchial beta-adrenoceptor antagonistic potencies of atenolol, metoprolol, acebutolol, practolol, propranolol and pindolol in the anaesthetized dog.
Harms HH; Spoelstra AJ
Clin Exp Pharmacol Physiol; 1978; 5(1):53-9. PubMed ID: 25152
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenoceptor antagonists and the release of creatine phosphokinase from hypoxic heart muscle.
Nayler WG; Grau A; Yepez C
Cardiovasc Res; 1977 Jul; 11(4):344-52. PubMed ID: 19152
[TBL] [Abstract][Full Text] [Related]
20. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
Boucher M; Duchêne-Marullaz P; Moundanga JL
Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
